Linda E Klumpers

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Multidrug Resistant

Stem Cell Transplantation

Depressive Symptoms

Top Venues

Cannabis and cannabinoid research

Journal of psychopharmacology (Oxford, England)

Clinical pharmacology and therapeutics

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Jan Rožanc, Linda E Klumpers, Marilyn Ann Huestis, Michael Tagen
Tolerability of High-Dose Oral Δ 9 -THC: Implications for Human Laboratory Study Design. Cannabis and cannabinoid research 9 (2) (2024)
Jan Rožanc, Linda E Klumpers, Marilyn Ann Huestis, Michael Tagen
Tolerability of High-Dose Oral Δ 9 -THC: Implications for Human Laboratory Study Design. Cannabis and cannabinoid research 9 (2) (2024)
Andriy A Gorbenko, Jules A A C Heuberger, Linda E Klumpers, Marieke L de Kam, Pamela K Strugala, Saco J de Visser, Geert Jan Groeneveld
Cannabidiol Increases Psychotropic Effects and Plasma Concentrations of Δ 9 -Tetrahydrocannabinol Without Improving Its Analgesic Properties. Clinical pharmacology and therapeutics (2024)
Michael Tagen, Daniel Mantuani, Liron van Heerden, Alex Holstein, Linda E Klumpers, Richard Knowles
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease. Journal of psychopharmacology (Oxford, England) (2023)
Michael Tagen, Linda E Klumpers
Review of delta-8-tetrahydrocannabinol (Δ 8 -THC): Comparative pharmacology with Δ 9 -THC. British journal of pharmacology 179 (15) (2022)